Steve Maletzky

Steve Maletzky

Managing Director, Equity Capital Markets
+1 312 364 8258
E-mail vCard
Education Tulane University, B.S.M.
Joined William Blair & Company 2010
Other Experience Cowen & Company
UBS Investment Bank
Needham & Company
Board Membership(s) The Nora Project
Notable Transactions
  • Phreesia, Inc. - initial public offering, joint bookrunner
  • Health Catalyst, Inc. - initial public offering, joint bookrunner
  • Vapotherm, Inc - initial public offering and follow-on offering, joint bookrunner
  • LogicBio Therapeutics, Inc. - initial public offering, joint bookrunner
  • Viking Therapeutics, Inc. - confidentially marketed follow-on, sole bookrunner
  • Assembly Biosciences, Inc. - confidentially marketed follow-on, joint bookrunner
  • Albireo Pharma, Inc. - confidentially marketed follow-on, joint bookrunner
  • Tactile Systems Technology, Inc. - initial public offering and follow-on offering, joint bookrunner
  • Neogenomics Inc. - confidentially marketed follow-on, joint bookrunner
  • Eagle Pharmaceuticals - initial public offering and follow-on offering, joint bookrunner